Algo version: 0.98b
Thyrocare Technologies is listed at the NSE Exchange
Thyrocare Technologies [THYROCARE.NS]
NSE Sector: Healthcare Industry:Diagnostics & Research

Is Thyrocare Technologies stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Thyrocare Technologies pays dividends. Last time was Sunday 22nd of September 2024 where the investors holding the stock on Friday 16th of August 2024 were paid INR18 per share. Over the last 12 times between 2016 and 2024, Thyrocare Technologies has paid INR123.5 with an average of INR10.29 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Thyrocare Technologies 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR467.65, you would have made a profit of INR390.00 per share or 83.40%

Yes, the average daily trading liquidity for Thyrocare Technologies is INR200 560 thousand. You should therefore be able to get in and out of your positions relatively fast.

Thyrocare Technologies has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 2.22, the company's ability to pay off the debt is good. Thyrocare Technologies has a good net profit margin of 12.37% and should have high tolerances against inflation.

We have calculated the inflation risk for Thyrocare Technologies to be low [0.1 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.